VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure

Phase 1

Completed

Conditions: Heart Failure

Interventions: Drug: Anakinra

First Posted Date: 2011-02-21

Last Posted Date: 2017-11-30

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 11

Registration Number: NCT01300650

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Not Applicable

Completed

Conditions: Ductal Breast Carcinoma in Situ
Lobular Breast Carcinoma in Situ
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage II Breast Cancer

Interventions: Procedure: Neoadjuvant Therapy
Procedure: Therapeutic Conventional Surgery
Other: Laboratory Biomarker Analysis
Genetic: Gene Expression Analysis
Drug: Tamoxifen Citrate
Drug: Systemic Chemotherapy
Drug: Aromatase Inhibition Therapy

First Posted Date: 2011-02-10

Last Posted Date: 2016-07-12

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 59

Registration Number: NCT01293032

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇺🇸
Cone Health Cancer Center, Greensboro, North Carolina, United States
🇺🇸
Forsyth Regional Cancer Center, Charlotte, North Carolina, United States

and more 5 locations

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Phase 1

Terminated

Conditions: Salivary Gland Squamous Cell Carcinoma
Stage III Salivary Gland Cancer
Stage III Squamous Cell Carcinoma of the Oropharynx
Stage IV Verrucous Carcinoma of the Oral Cavity
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
Stage IV Salivary Gland Cancer
Stage IV Squamous Cell Carcinoma of the Oropharynx
Stage III Squamous Cell Carcinoma of the Hypopharynx
Stage IV Squamous Cell Carcinoma of the Hypopharynx
Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity

Interventions: Radiation: intensity-modulated radiation therapy
Drug: cisplatin
Radiation: image-guided adaptive radiation therapy
Other: 3'-deoxy-3'-[18F]fluorothymidine
Procedure: positron emission tomography/computed tomography
Radiation: fludeoxyglucose F 18

First Posted Date: 2011-01-25

Last Posted Date: 2016-10-31

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 3

Registration Number: NCT01283178

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Behavioral Incentives to Increase Exercise in Cocaine Dependent Women

Not Applicable

Completed

Conditions: Cocaine Dependence

Interventions: Behavioral: Education Control
Behavioral: Behavioral Incentives

First Posted Date: 2011-01-25

Last Posted Date: 2014-12-18

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 26

Registration Number: NCT01283191

Locations: 🇺🇸
Rubicon, Inc., Richmond, Virginia, United States

Nerve Growth Factor in Chronic Pancreatitis

Completed

Conditions: Chronic Pancreatitis

First Posted Date: 2010-12-08

Last Posted Date: 2016-03-07

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 38

Registration Number: NCT01255917

Locations: 🇺🇸
Virginia Commonwealth University Medical Center, Richmond, Virginia, United States

Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

Phase 2

Terminated

Conditions: Metabolic Syndrome
Nonalcoholic Fatty Liver Disease

Interventions: Drug: Sodium Octanoate Breath Test

First Posted Date: 2010-11-19

Last Posted Date: 2015-07-28

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 61

Registration Number: NCT01244503

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Hyperbaric Oxygen Therapy (HBO2T) for Post-Concussive Symptoms (PSC) After Mild Traumatic Brain Injury (mTBI)

Phase 2

Completed

Conditions: Mild Traumatic Brain Injury
Post-Concussive Syndrome

Interventions: Procedure: Hyperbaric Oxygen Therapy

First Posted Date: 2010-10-14

Last Posted Date: 2013-08-27

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 60

Registration Number: NCT01220713

Locations: 🇺🇸
Naval Medical Center Portsmouth, Portsmouth, Virginia, United States
🇺🇸
Hunter Holmes McGuire Veterans' Affairs Medical Center, Richmond, Virginia, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: lorazepam
Drug: diphenhydramine hydrochloride
Drug: haloperidol
Other: questionnaire administration
Other: laboratory biomarker analysis

First Posted Date: 2010-09-17

Last Posted Date: 2017-11-17

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 11

Registration Number: NCT01204255

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer

Not Applicable

Completed

Conditions: Cancer-related Problem/Condition
Neurotoxicity
Pain
Peripheral Neuropathy

Interventions: Other: electrical stimulation pain therapy
Other: questionnaire administration

First Posted Date: 2010-09-08

Last Posted Date: 2013-08-23

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 39

Registration Number: NCT01196442

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Anakinra to Prevent Adverse Post-infarction Remodeling (2)

Phase 2

Completed

Conditions: Heart Failure
Acute Myocardial Infarction

Interventions: Drug: Placebo
Drug: Anakinra

First Posted Date: 2010-08-04

Last Posted Date: 2016-05-23

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 30

Registration Number: NCT01175018

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy